找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Russia’s Domestic Security Wars; Putin’s Use of Divid Peter Reddaway Book 2018 The Editor(s) (if applicable) and The Author(s) 2018 Russia.

[復(fù)制鏈接]
樓主: Clinton
31#
發(fā)表于 2025-3-26 23:13:25 | 只看該作者
32#
發(fā)表于 2025-3-27 01:30:09 | 只看該作者
Peter Reddawayly a small proportion of the population. Although tumor size, histologic grade, and steroid receptor status provide information suggesting recurrence risk for large groups of patients, there remains no satisfactory tool for accurate prediction of recurrence in the individual.
33#
發(fā)表于 2025-3-27 05:25:45 | 只看該作者
34#
發(fā)表于 2025-3-27 11:55:14 | 只看該作者
35#
發(fā)表于 2025-3-27 15:28:35 | 只看該作者
Peter Reddawayt at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid- ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua- tion of the first book. A refined risk assessment at 978-3-642-74730-4978-3-642-74728-1
36#
發(fā)表于 2025-3-27 20:42:21 | 只看該作者
Peter Reddaway as discussed by Neidhart (this volume), over the more conventionally used regimen of using a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF) is emerging as a result of several recent studies. The whole issue of dose intensity, discussed in more detail by Hryniuk et al. (this v
37#
發(fā)表于 2025-3-28 00:00:46 | 只看該作者
Peter Reddaway as discussed by Neidhart (this volume), over the more conventionally used regimen of using a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF) is emerging as a result of several recent studies. The whole issue of dose intensity, discussed in more detail by Hryniuk et al. (this v
38#
發(fā)表于 2025-3-28 04:28:12 | 只看該作者
39#
發(fā)表于 2025-3-28 07:49:34 | 只看該作者
Peter Reddawayosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid- ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua- tion of the first book. A refined risk assessment at
40#
發(fā)表于 2025-3-28 13:57:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 17:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
芦山县| 清远市| 铁力市| 正宁县| 蓬莱市| 洪湖市| 佛山市| 靖安县| 襄汾县| 石家庄市| 吴桥县| 碌曲县| 米脂县| 信阳市| 夏津县| 多伦县| 波密县| 淮阳县| 丁青县| 高安市| 太白县| 漳州市| 邢台县| 湖南省| 晴隆县| 开化县| 尼玛县| 安溪县| 山阳县| 抚顺市| 耒阳市| 灵山县| 巴中市| 自治县| 新巴尔虎右旗| 云南省| 镇康县| 顺义区| 荣成市| 潞西市| 固安县|